

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported...


(Sharecast News) - TheraCryf said on Monday that its lead Ox-1 receptor antagonist programme for addiction had advanced to final toxicology studies, k...


(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported...


(Sharecast News) - TheraCryf said on Monday that it has received a notice of allowance from the Canadian Patent Office for its Orexin-1 addiction prog...


TheraCryf PLC - Cheshire, England-based pharmaceutical firm focused on cancer and brain disorders - Says it started 2026 positively by reaching a key ...


(Alliance News) - The following stocks are the leading risers and fallers on AIM on Monday.


(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Wednesday and not separately reported by Alliance New...